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Of all malignant neoplasms, human oesophageal carcinoma is
among the tumours with the poorest prognosis (Sugimachi et al,
1988). Similar to other malignant tumours, this undesirable
prognosis in the patients with oesophageal carcinomas has been
attributed to invasion and metastasis (Sugimachi et al, 1988). In
oesophageal carcinomas, lymph node metastasis and invasion to
the neighbouring organs such as the aorta, trachea and bronchus,
pericardium and lungs are the most important event in the failure
of the treatment of oesophageal carcinomas. Therefore, it is a
major goal to identify the molecular mechanisms of invasion and
metastasis of the oesophageal carcinomas. Although molecular
studies on human oesophageal carcinogenesis have revealed
frequent genetic abnormalities including c-myc amplification
(Lu et al, 1988), epidermal growth factor receptor amplification
(Lu et al, 1988), p53 mutations (Hollstein et al, 1990) and cyclin
D1 overexpression (Nakagawa et al, 1995), very little is known
about the role of these alterations in the mechanisms of invasion
and metastasis of this type of cancer.
Metastasis is a complex series of events that involves several
gene products, including those important in the detachment of
neoplastic cells from the primary tumour, penetration into the
blood and lymphatics, arrest at distant sites by adhesion to
endothelial cells and underlying matrix, extravasation, the induc-
tion of angiogenesis, evasion of host anti-tumour responses, and
the growth at metastatic sites (Nicolson, 1988; Liotta et al, 1991).
To identify the genes involved in cancer metastasis, we previously
performed differential cDNA library screening using the 13762NF
rat mammary adenocarcinoma metastatic system (Pencil et al,
1993) and we found a novel candidate metastasis-associated gene
mta1 (Toh et al, 1994, 1995). Using the same or a similar method,
several metastasis-associated genes have thus been isolated,
including  nm23,  mts-1, WDNM1, WDNM2, elongation factor 1a,
stromelysin 3 and pGM21 (Dear et al, 1988, 1989; Steeg et al,
1988; Ebralidze et al, 1989; Basset et al, 1990; Phillips et al, 1990;
Taniguchi et al, 1992). With the exception of a few of these genes,
such as nm23 and stromelysin 3 (Steeg et al, 1988; Basset et al,
1990), however, few studies have examined the relationship
between the expression of the genes in human carcinoma tissues
and their clinicopathological features.
Our previous study showed that the mRNA expression level of
mta1 gene was fourfold higher in the highly metastatic mammary
adenocarcinoma cell line MTLn3 than in the non-metastatic line
MTC.4. The mRNA expression levels of the human homologue of
this gene also correlated with metastatic potential in several human
breast cancer metastatic systems. The mta1 gene encodes a protein
of the molecular mass of ~80 kDa and the correlation observed at
mRNA level was also confirmed at the protein level. Although the
function of mta1 or its human counterpart MTA1 gene product
remains unknown, the deduced amino acid sequence suggests that
the mta1/MTA1 protein might be involved in a signal transduction
pathway or regulation of gene expression (Toh et al, 1994, 1995).
To determine whether the mta1/MTA1 gene plays a role in cancers
other than those of the breast, we recently examined the expression
of the MTA1 gene in surgically resected specimens of colorectal
and gastric carcinomas and their corresponding normal mucosa
tissues, and we found that overexpression of the MTA1 gene was
related to degree of invasion and lymphatic metastasis in these
carcinomas (Toh et al, 1997). We have now extended our research
to oesophageal carcinomas and have found a correlation between
MTA1 gene overexpression and tumour invasiveness.
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Surgical specimens and isolation of total cellular RNA
Oesophageal carcinomas and paired normal mucosa were resected
and snap-frozen in liquid nitrogen, immediately after surgical
resection. The carcinoma tissue samples were obtained from a
portion of the resected specimens after excluding necrotic or ulcer-
ated parts and normal adjacent tissues. Specimens were stored at
–80°C until the total RNA was extracted. Forty-seven oesophageal
carcinomas along with their corresponding normal mucosa were
obtained at Kyushu University Hospital and its facilitated hospi-
tals in Japan during the 2-year period from 1995 to 1997.
Total cellular RNA was isolated from carcinomas and normal
epithelia according to the method described by Chomzynski and
Sacchi (1987) using Isogen (Nippon Gene, Tokyo, Japan) containing
phenol and guanidine isothionate in a monophasic solution.
cDNA synthesis by reverse transcription (RT) and
quantitative RT-polymerase chain reaction (RT-PCR)
The methods for cDNA synthesis and optimization of quantitative
RT-PCR for clinical samples were described in detail in our
previous paper (Toh et al, 1997). The relative amounts of MTA1
expression were normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) expression, and the MTA1 expression
in the carcinoma tissue (T) was compared with that in the corre-
sponding normal mucosa (N). The tumour/normal ratio of MTA1
expression (T/N ratio) in each case was calculated. To minimize
variation, each PCR was performed in triplicate and the average
expression of MTA1 was compared between the carcinoma and
the normal mucosa.
Statistical analysis
All data regarding the clinical and histopathological variables
were stored in a Macintosh computer. The Stat View program
(Abacus Concepts, Berkeley, CA, USA) was used for all statistical
analyses, using the chi-squared test and Fisher’s exact probability
test. A P-value less than 0.05 was judged to be statistically
significant.
RESULTS
To quantitate the relative levels of MTA1 gene expression by RT-
PCR and to compare the expression in paired carcinoma and
normal epithelium samples, we previously determined the optimal
conditions for proportional production of PCR product with
amount of RNA template and the number of PCR cycles (Toh et al,
1997). Briefly, the result for MTA1 indicates a linear relationship
between the amount of PCR product and the number of PCR
cycles between 30 and 34. Additional cycles reduced the linearity
of the amplification response, whereas with fewer cycles the sensi-
tivity of the PCR method decreased. This linear response was
observed with three different starting amounts (0.5, 1.0 and
2.0 mg) of total RNA. Therefore, in this study, 32 cycles of ampli-
fication and 1.0 mg of total RNA were used for the RT-PCR
analysis of MTA1 gene expression. Similar experiments were
performed for the RT-PCR of GAPDH mRNA, and the optimal
conditions were determined to be 25 cycles of amplification and
1.0 mg of total RNA.
Having confirmed the reproducibility of our quantitative RT-
PCR assay for MTA1 gene expression, we analysed the relative
expression of MTA1 mRNA in the 47 surgically resected
oesophageal carcinomas and compared them with the corre-
sponding normal mucosa tissues. All of the normal oesophageal
mucosa expressed MTA1 mRNA in relatively low amounts. Using
densitometric analysis of the PCR products, we estimated over-
expression (T/N ratio ³ 2) of the MTA1 mRNA compared with the
normal mucosa in 16 out of 47 cases (34.0%), whereas, in the
remaining 31 cases, the expression of MTA1 mRNA was similar in
the carcinoma and normal mucosa tissues. The representative
cases that overexpressed MTA1 mRNA are shown in Figure 1.
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Table 1 Clinicopathological features of oesophageal carcinomas with
regard to the relative expression of MTA1 mRNA
Relative expression of MTA1 mRNA
Variables Tumor/normal ³2 Tumor/normal <2
(n=16) (n=31) P-values
Age (years) 61.5±10.4 64.6±10.9 0.346
Sex
Male/female 14:2 27:4 0.969
Location 0.760
Upper third 2 3
Middle third 10 17
Lower third 4 11
Histology 0.777
Well differentiated SCCa 47
Moderately differentiated SCC 8 18
Poorly differentiated SCC 4 5
Small-cell carcinoma 0 1
Depth of invasion 0.031c
Within the wall 4 18
Invaded into adventitia/
neighbouring structures 12 13
Lymph node metastasis 0.030c
Negative 5 20
Positive 11 11
Stageb 0.121
0+I+II 6 19
III+IV 10 12
Lymphatic involvement 0.081
Negative 5 18
Positive 11 13
Vascular involvement 0.337
Negative 8 20
Positive 8 11
aDifferentiated squamous cell carcinoma; bthe criteria used in this study are
based on the rules established by the Japanese Society for Oesophageal
Disease (1976); cstatistically significant.
N T N T N T N T
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Figure 1 MTA1 mRNA expression in representative cases of oesophageal
carcinomas as determined by the RT-PCR method. T represents tumour
tissue and N represents the corresponding normal mucosa tissue. GAPDH is
used as an internal controlThe relationship between expression of the MTA1 gene and
clinicopathological data of the oesophageal carcinomas was exam-
ined. In the oesophageal carcinoma cases, we arbitrarily divided
the samples into two groups depending on the level of expression
of the MTA1 gene in the tumour samples (T/N ratio ³ 2 and T/N
ratio < 2) (Table 1). Clinicopathological studies demonstrated that
12 out of 16 oesophageal carcinomas overexpressing this gene
(T/N ratio ³ 2) invaded into the adventitia or the neighbouring
structures, whereas 13 out of 31 remaining tumours (T/N ratio < 2)
were restricted in the proper muscle layer (P < 0.05). Furthermore,
MTA1-overexpressing tumours had a significantly higher rate of
lymph node metastasis (P < 0.05) and tended to have a higher rate
of lymphatic involvement (P = 0.081). No statistically significant
differences were observed in age, sex, location of the main tumour,
histological differentiation, stage and vascular involvement.
DISCUSSION
About 85% of patients with oesophageal carcinomas are in an
advanced stage of the disease at the time of the operation
(Sugimachi et al, 1994), and approximately 40% of these patients
have either local tumour invasion into the neighbouring structures
or lymph node metastases that preclude complete removal of the
cancers (Sugimachi et al, 1994). Furthermore, the histological
findings of lymph node metastasis and the presence of vascular or
lymphatic invasion by cancer cells have been widely accepted
as unfavourable prognostic factors (Sugimachi et al, 1988).
Therefore, to improve the outcome of the treatment of this disease,
it may be necessary not only to diagnose this disease at an early
stage but also to understand the molecular mechanisms of invasion
and metastasis of oesophageal carcinomas.
Here, we showed that MTA1 gene could be another candidate
factor that is associated with invasion and metastasis of
oesophageal carcinomas. Previously, we found that MTA1 mRNA
was also overexpressed in other tumour tissues in comparison to
the normal mucosal tissues (T/N ratio ³ 2), e.g. in 38.9% of
colorectal carcinomas and 38.2% of gastric carcinomas. The
colorectal and gastric carcinoma tumours that overexpressed
MTA1 mRNA also showed deeper invasion and higher rates of
lymph node metastasis (Toh et al, 1997). That overexpression of
the MTA1 mRNA was significantly correlated with tumour inva-
siveness in three independent carcinoma types strongly suggests
the possibility that MTA1 is one of the key molecules associated
with tumour invasion and metastasis.
Although the exact function of the mta1/MTA1 gene product is
still unknown, its deduced amino acid sequence suggests that this
protein is involved in a signal transduction pathway (Toh et al,
1994; 1995). The protein motifs of the MTA1 gene product
suggested that there are potential phosphorylation sites for tyrosine
kinases, protein kinase C and casein kinase II. In addition, a
proline-rich amino acid sequence (LPLRPPPPAP) exists at the
carboxy-terminal extremity that completely matches the consensus
sequence for a src homology 3 domain (SH3)-binding site (Ren et
al, 1993; Yu et al, 1994). SH3 domains are considered important in
protein–protein interactions in signal transduction pathways
(Pawson and Gish, 1992), and they are often associated with
cytoskeletal components (Bar-Sagi et al, 1993) as well as being
involved in other protein–protein interactions (Seidel-Dugan et al,
1992).
Recently, Paterno et al (1997) reported a novel, developmentally
regulated, immediate early gene named er 1 which is activated by
fibroblast growth factor in Xenopus embryos. The predicted ER1
amino acid sequence (accession number AF015454) contains three
regions of similarity to mta1/MTA1 gene product which are in turn
similar to the MTA1-like sequence found in a C.e legans protein
(accession number U41264). The er1 gene has been shown to be
a potent transcription factor and it also contains a SH3-binding
domain. Although the er1 gene does not seem to be a Xenopus
homologue of the rat mta1 gene, the data suggest that they are
related members of a gene family with the same or similar func-
tions. Indeed, the amino acid sequence of mta1/MTA1 contains a
Zinc-finger motif which is important in some transcription factors.
Therefore, it may be possible that mta1/MTA1 protein regulates the
expression of a set of proteins which are associated with invasion
and metastasis of oesophageal carcinoma cells. For example,
Shima et al (1992) reported that matrix metalloproteinase
2 (72 kDa type IV collagenase) and stromelysin were expressed
in a portion of the oesophageal carcinomas and they found a good
correlation between expression of the matrix metalloproteinase
and lymph node metastasis and vascular invasion. Using immuno-
histochemistry, Kadowaki et al (1994) examined the expressions
of E-cadherin and a-catenin in oesophageal squamous cell carci-
nomas. They found that the reduction of a-catenin and E-cadherin
expression was significantly associated with increased invasive-
ness and lymph node metastasis. Thus, it is of interest to investi-
gate the relationship between the expression of metastasis-
associated proteins described above and that of mta1/MTA1 gene
product in oesophageal carcinomas. For this purpose, immunohis-
tochemical co-localization of these proteins in resected
oesophageal specimens and artificial overexpression mta1/
MTA1 gene in oesophageal carcinoma cell lines followed by in
vitro assays for invasion, motility and adhesion will be required.
In conclusion, our studies have shown that the expression of the
MTA1 gene is closely related to the invasiveness of oesophageal
carcinomas as well as gastric and colorectal carcinomas. The novel
MTA1 gene could thus potentially provide new information on the
mechanism of invasion and metastasis of the gastrointestinal
cancers. To elucidate the association of this gene with invasion
and metastasis, transfection studies using sense and antisense
mta1/MTA1 cDNA expression plasmids will be necessary. In addi-
tion, it is also important to examine MTA1 mRNA expression in
various other human cancers, and future studies should therefore
include breast, lung and other cancer specimens. Such studies are
presently in progress in our laboratories.
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